Healthcare -
Biotechnology - NASDAQ - US
$ 5.25
8.25 %
$ 111 M
Market Cap
-0.96
P/E
ENTA - OTHER CURRENT LIABILITIES
Other Current Liabilities ENTA - Enanta Pharmaceuticals, Inc.
46.5 M
LAST VALUE
60.50%
2 YEAR CAGR
23.90%
5 YEAR CAGR
32.10%
10 YEAR CAGR